Login

Kite Pharma, Inc. 4 SEC Filings

Filed On Filing
05 Oct 2017 Form 4: Peacock Jonathan M, Director

Gave 635 shares as a gift · Disposed of 67,932 shares (Tender Offer) ($12.2M) · Returned 1,807 shares to the issuer · 1 more

05 Oct 2017 Form 4: Clark Ian T, Director

Disposed of 1,776 shares (Tender Offer) ($320K) · Returned 5,324 shares to the issuer · Disposed of 25,940 Director Stock Option (Right to Buy) (Disposition to Issuer) ($3.08M)

05 Oct 2017 Form 4: Nussbaum Ran, Director

Returned 14,192 shares to the issuer · Disposed of 75,810 Director Stock Option (Right to Buy) (Disposition to Issuer) ($11.8M)

05 Oct 2017 Form 4: Kazam Joshua A, Director

Acquired 70,050 shares (Other Transaction) · Returned 71,857 shares to the issuer · Disposed of 2,553 shares (Tender Offer) ($460K) · 1 more

05 Oct 2017 Form 4: Humer Franz B, Director

Disposed of 4,624 shares (Tender Offer) ($832K) · Returned 1,807 shares to the issuer · Disposed of 35,810 Director Stock Option (Right to Buy) (Disposition to Issuer) ($4.16M)

05 Oct 2017 Form 4: Doumani Roy, Director

Disposed of 175,685 shares (Tender Offer) ($31.6M) · Returned 1,807 shares to the issuer · Disposed of 55,810 Director Stock Option (Right to Buy) (Disposition to Issuer) ($8.09M)

05 Oct 2017 Form 4: Bonderman David, Director

Returned 2,412,444 shares to the issuer · Disposed of 75,810 Director Stock Option (Right to Buy) (Disposition to Issuer) ($11.8M)

05 Oct 2017 Form 4: Ruchefsky Steven B, Director

Gave 2,250 shares as a gift · Returned 205,586 shares to the issuer · Disposed of 275,810 Director Stock Option (Right to Buy) (Disposition to Issuer) ($47.7M)

05 Oct 2017 Form 4: Champsi Farah, Director

Gave 2,800 shares as a gift · Disposed of 61,467 shares (Tender Offer) ($11.1M) · Returned 1,807 shares to the issuer · 1 more

05 Oct 2017 Form 4: Witte Owen N., Director

Gave 12,000 shares as a gift · Disposed of 58,535 shares (Tender Offer) ($10.5M) · Returned 5,715 shares to the issuer · 2 more

05 Oct 2017 Form 4: Moore Timothy L., EVP, Technical Operations

Disposed of 3,927 shares (Tender Offer) ($707K) · Returned 41,734 shares to the issuer · Disposed of 251,700 Employee Stock Option (Right to Buy) (Disposition to Issuer)

05 Oct 2017 Form 4: Tomasello Shawn, Chief Commercial Officer

Gave 5,000 shares as a gift · Disposed of 16,135 shares (Tender Offer) ($2.9M) · Returned 39,933 shares to the issuer · 1 more

05 Oct 2017 Form 4: Wiezorek Jeffrey, SVP Clinical Development

Disposed of 14,674 shares (Tender Offer) ($2.64M) · Returned 11,150 shares to the issuer · Disposed of 139,000 Employee Stock Option (Right to Buy) (Disposition to Issuer)

05 Oct 2017 Form 4: Kim Helen Susan, EVP, Business Development

Disposed of 4,193 shares (Tender Offer) ($755K) · Returned 17,500 shares to the issuer · Disposed of 165,251 Employee Stock Option (Right to Buy) (Disposition to Issuer)

05 Oct 2017 Form 4: Jenkinson Paul L, Chief Financial Officer

Returned 12,462 shares to the issuer · Disposed of 149,200 Employee Stock Option (Right to Buy) (Disposition to Issuer)

05 Oct 2017 Form 4: Chang David D, EVP, R&D, Chief Medical Off.

Gave 375 shares as a gift · Gave 1,041 shares as a gift · Gave 157 shares as a gift · 4 more

05 Oct 2017 Form 4: Butitta Cynthia M, Chief Operating Officer

Gave 27,900 shares as a gift · Returned 93,667 shares to the issuer · Disposed of 461,605 Employee Stock Option (Right to Buy) (Disposition to Issuer)

05 Oct 2017 Form 4: Belldegrun Arie, Director

Received 50,000 shares as a grant or award · Returned 3,356,429 shares to the issuer · Disposed of 399,600 Employee Stock Option (Right to Buy) (Disposition to Issuer)

27 Sep 2017 Form 4: Tomasello Shawn, Chief Commercial Officer

Received 4,500 shares as a grant or award · Sold 4,203 shares ($755K)

27 Sep 2017 Form 4: Kim Helen Susan, EVP, Business Development

Received 6,000 shares as a grant or award · Sold 3,171 shares ($570K)

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support